TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Zacks Downgrades Genzyme to 'Underperform' Research Recap submits: Genzyme (GENZ) has been under a lot of pressure over the past few quarters following the temporary shutdown of its Allston manufacturing facility due to contamination problems. While we are pleased to see that Genzyme is taking steps to emerge from the impact of the temporary shutdown of the Allston plant, we believe that the company may have to face additional challenges before it is able to go back to a normal production and supply schedule.Complete Story » seekingalpha.com |
Six Trades on FDA, Clinical Trial Binary Events Mike Havrilla submits:Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news... BioSante Pharma (NASDAQ:BPAX)Complete Story » seekingalpha.com |
Pfizer's Profit Climbs Pfizer's earnings rose 9.5% as the company's revenue was again boosted by its acquisition of Wyeth, while sales of its flagship drugs rose. online.wsj.com |
A Different Kind of Eyeglasses Zoom Focus Eyewear wins the Silver award in The Wall Street Journal's 2010 Technology Innovation Awards for eyeglasses that the wearer can manually adjust to give clear vision at any distance online.wsj.com |
J&J Profit Edges Higher Johnson & Johnson eked out a profit, even though sales were down slightly, hurt by repeated product recalls. online.wsj.com |